John Holyoake

By January 22, 2019

Senior Director, New Ventures (Canada), Johnson & Johnson Innovation Advisor, Managing Director, Investment Banking Bloom Burton & Co.


John Holyoake, Managing Director, Investment Banking, joined Bloom Burton & Co. in January 2012. At Bloom Burton, John’s responsibilities also include overseeing Monetization Planning, Bloom Burton’s strategic consulting service, and supporting Bloom Burton’s portfolio of incubated companies.

John currently serves on the Board of directors of Appili Therapeutics, Satellos Bioscience, The Canadian Glycomics Network (GlycoNet), and Triumvira Immunologics. Additionally, John advises Canada’s research institutions on their commercialization efforts, including as part of GlycoNet’s commercialization committee and as a member of the Core Evaluation Team for Genome Canada’s Genomic Applications Partnership Program.

John holds a Master’s in Biochemistry and Doctorate from the University of Oxford, and carried out post-doctoral research at The Hospital for Sick Children, Toronto.